NDC 66267-132 – Loperamide Hydrochloride
Loperamide Hydrochloride 2 mg/1 · Capsule · Oral
Product NDC66267-132
Product details
- Brand name
- Loperamide Hydrochloride
- Generic name
- Loperamide Hydrochloride
- Labeler
- NuCare Pharmaceuticals, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA073192
- Marketed since
- May 1, 1993
- Listing expires
- December 31, 2026
- Pharmacologic class
- Opioid Agonist
Active ingredients
- Loperamide Hydrochloride 2 mg/1
Uses, dosage, side effects and warnings for Loperamide Hydrochloride →
Package NDC codes (5)
| Package NDC | Description | Since |
|---|---|---|
| 66267-132-12 | 12 CAPSULE in 1 BOTTLE (66267-132-12) | Oct 10, 2016 |
| 66267-132-15 | 15 CAPSULE in 1 BOTTLE (66267-132-15) | Oct 10, 2016 |
| 66267-132-18 | 18 CAPSULE in 1 BOTTLE (66267-132-18) | Oct 10, 2016 |
| 66267-132-20 | 20 CAPSULE in 1 BOTTLE (66267-132-20) | Oct 10, 2016 |
| 66267-132-60 | 15 CAPSULE in 1 BOTTLE (66267-132-60) | Dec 28, 2017 |
Other Loperamide Hydrochloride products
- 50090-0460 Loperamide Hydrochloride 2 mg/1 · Capsule · A-S Medication Solutions
- 50090-7398 Loperamide Hydrochloride 2 mg/1 · Capsule · A-S Medication Solutions
- 72888-130 Loperamide Hydrochloride 2 mg/1 · Capsule · Advagen Pharma Ltd.,
- 60468-005 Loperamide Hydrochloride 2 mg/1 · Capsule · allphamed Pharbil Arzneimittel GmbH
- 60687-229 Loperamide Hydrochloride 2 mg/1 · Capsule · American Health Packaging
- 71610-648 Loperamide Hydrochloride 2 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-950 Loperamide Hydrochloride 2 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-973 Loperamide Hydrochloride 2 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-781 Loperamide Hydrochloride 2 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 59651-691 Loperamide Hydrochloride 2 mg/1 · Capsule · Aurobindo Pharma Limited
- 50268-482 Loperamide Hydrochloride 2 mg/1 · Capsule · AvPAK
- 69452-271 Loperamide Hydrochloride 2 mg/1 · Capsule · Bionpharma Inc.